- Healthcare and industrial adhesives group Scapa posted a first-half loss after it was hurt by reduced volumes, though the blow was partly offset by cost cutting and government support.

Pre-tax losses for the six months through September amounted to £0.5 million, compared to losses of £1.0 million year-on-year.

Revenue fell 24% to £122.0 million, though it improved 23% sequentially from the first quarter to the second.

Scapa said demand in its healthcare division was hurt by a postponement of elective surgeries and reduced footfall across retail channels.

There had been early signs of improvement in the third quarter, albeit cautious given the recent global resurgence of Covid-19 infections.

Demand in the industrial division had recovered to pre-Covid-19 levels at the end of the second quarter, which was expected to positively impact revenues in the second half.

'Whilst uncertainty remains given the recent global resurgence of Covid-19 infections, revenue in both divisions in the second half is expected to exceed the first, with earnings benefitting from additional volumes and cost improvement programmes already implemented,' the company said.

At 9:15am: [LON:SCPA] Scapa Group PLC share price was 0p at 148.4p

Story provided by